These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

994 related articles for article (PubMed ID: 10950365)

  • 1. The epidemiology of acquired immunodeficiency syndrome malignancies.
    Goedert JJ
    Semin Oncol; 2000 Aug; 27(4):390-401. PubMed ID: 10950365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Epidemiology of HIV-associated malignancies].
    Launay O; Guillevin L
    Bull Cancer; 2003 May; 90(5):387-92. PubMed ID: 12850760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opportunistic malignancies and the acquired immunodeficiency syndrome.
    Mueller N; Hatzakis A
    Princess Takamatsu Symp; 1987; 18():159-71. PubMed ID: 3506539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AIDS malignancies in the era of highly active antiretroviral therapy.
    Gates AE; Kaplan LD
    Oncology (Williston Park); 2002 May; 16(5):657-65; discussion 665, 668-70. PubMed ID: 12108891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy.
    Clifford GM; Polesel J; Rickenbach M; Dal Maso L; Keiser O; Kofler A; Rapiti E; Levi F; Jundt G; Fisch T; Bordoni A; De Weck D; Franceschi S;
    J Natl Cancer Inst; 2005 Mar; 97(6):425-32. PubMed ID: 15770006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Less cancer--or more--with HAART? Or, reflections on a late opus.
    Mascolini M
    J Int Assoc Physicians AIDS Care; 1998 Jun; 4(6):12-22. PubMed ID: 11365531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of highly active antiretroviral therapy on the incidence and outcomes of AIDS-defining cancers in Southern Alberta.
    Gingues S; Gill MJ
    HIV Med; 2006 Sep; 7(6):369-77. PubMed ID: 16903981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AIDS-related malignancies: emerging challenges in the era of highly active antiretroviral therapy.
    Cheung MC; Pantanowitz L; Dezube BJ
    Oncologist; 2005; 10(6):412-26. PubMed ID: 15967835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AIDS malignancies in the era of highly active antiretroviral therapy.
    Gates AE; Kaplan LD
    Oncology (Williston Park); 2002 Apr; 16(4):441-51, 456, 459. PubMed ID: 12017534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Underestimation of relative risks by standardized incidence ratios for AIDS-related cancers.
    Chaturvedi AK; Mbulaiteye SM; Engels EA
    Ann Epidemiol; 2008 Mar; 18(3):230-4. PubMed ID: 18083545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AIDS-associated malignancies.
    Krown SE
    Cancer Chemother Biol Response Modif; 1996; 16():441-61. PubMed ID: 8639393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors associated with the occurrence of AIDS-related non-Hodgkin lymphoma in the era of highly active antiretroviral therapy: Aquitaine Cohort, France.
    Bonnet F; Balestre E; Thiébaut R; Morlat P; Pellegrin JL; Neau D; Dabis F;
    Clin Infect Dis; 2006 Feb; 42(3):411-7. PubMed ID: 16392091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malignant tumors and AIDS.
    Nasti G; Vaccher E; Errante D; Tirelli U
    Biomed Pharmacother; 1997; 51(6-7):243-51. PubMed ID: 9309244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [AIDS associated cancers in the era of highly active antiretroviral therapy (HAART)].
    Tserenpuntsag B; Kołacińska A; Jabłonowska E
    Przegl Epidemiol; 2007; 61(3):529-34. PubMed ID: 18069390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human immunodeficiency virus-associated neoplasms: epidemiology, pathogenesis, and review of current therapy.
    Aboulafia DM
    Cancer Pract; 1994; 2(4):297-306. PubMed ID: 7858657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The changing pattern of AIDS-defining illnesses with the introduction of highly active antiretroviral therapy (HAART)in a London clinic.
    Ives NJ; Gazzard BG; Easterbrook PJ
    J Infect; 2001 Feb; 42(2):134-9. PubMed ID: 11531320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic approaches to AIDS-related malignancies.
    Berretta M; Cinelli R; Martellotta F; Spina M; Vaccher E; Tirelli U
    Oncogene; 2003 Sep; 22(42):6646-59. PubMed ID: 14528290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends in the incidence of acquired immunodeficiency syndrome-related malignancies in Thailand.
    Sriplung H; Parkin DM
    Cancer; 2004 Dec; 101(11):2660-6. PubMed ID: 15495138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Neoplastic manifestations of HIV infection].
    Laatiri MA; Ennabli S
    Tunis Med; 2003 Jan; 81(1):5-10. PubMed ID: 12708185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AIDS and non-Hodgkin's lymphoma. Experience at an oncological center in Mexico.
    Cornejo-Juárez P; Volkow-Fernández P; Avilés-Salas A; Calderón-Flores E
    Rev Invest Clin; 2008; 60(5):375-81. PubMed ID: 19227434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 50.